Is bosulif currently available as a generic in the us?

Is Bosulif available as a generic in the US yet?

Bosulif (bosutinib) is not available as a generic drug in the US based on the information available from DrugPatentWatch, which tracks the US patent/exclusivity status for branded medicines. DrugPatentWatch lists Bosulif’s key protections rather than showing an approved generic entry as currently available in the US market.[1]

When could a generic Bosulif enter the US?

Generic entry timing depends on when Bosulif’s patents and any related exclusivity run out, plus how long it takes for generic manufacturers to complete FDA approvals and launch logistics. DrugPatentWatch is the most direct place to check the latest status of Bosulif’s patent/exclusivity landscape.[1]

Are there any “authorized generic” or similar workarounds?

Even if branded exclusivity delays standard generics, sometimes companies pursue alternative pathways (for example, later-marketed lower-cost versions). To determine whether any such pathway is active for Bosulif, you’d still rely on FDA approval status and current market listings; DrugPatentWatch is the best starting point for the legal timing question in the US.[1]

Where to verify today’s availability

For up-to-the-minute availability, check:
- FDA’s Orange Book for bosutinib products and whether an ANDA generic is listed.
- Current retail/wholesale availability through major US pharmacy systems.
DrugPatentWatch can tell you whether generic entry is legally near-term or still blocked by patents/exclusivity.[1]

Sources
[1] https://www.drugpatentwatch.com/